These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27714550)

  • 21. Differential cerebellar functional interactions during an interference task across multiple sclerosis phenotypes.
    Rocca MA; Bonnet MC; Meani A; Valsasina P; Colombo B; Comi G; Filippi M
    Radiology; 2012 Dec; 265(3):864-73. PubMed ID: 22966067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limbic system damage in MS: MRI assessment and correlations with clinical testing.
    Wen J; Yablonskiy DA; Salter A; Cross AH
    PLoS One; 2017; 12(11):e0187915. PubMed ID: 29121642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
    Kearney H; Miszkiel KA; Yiannakas MC; Altmann DR; Ciccarelli O; Miller DH
    Mult Scler; 2016 Jun; 22(7):910-20. PubMed ID: 26432854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preserved brain adaptive properties in patients with benign multiple sclerosis.
    Rocca MA; Ceccarelli A; Rodegher M; Misci P; Riccitelli G; Falini A; Comi G; Filippi M
    Neurology; 2010 Jan; 74(2):142-9. PubMed ID: 20065249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olfactory dysfunction in multiple sclerosis: association with secondary progression.
    Silva AM; Santos E; Moreira I; Bettencourt A; Coutinho E; Gonçalves A; Pinto C; Montalban X; Cavaco S
    Mult Scler; 2012 May; 18(5):616-21. PubMed ID: 22020420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic Functional Connectivity in the Main Clinical Phenotypes of Multiple Sclerosis.
    Hidalgo de la Cruz M; Valsasina P; Sangalli F; Esposito F; Rocca MA; Filippi M
    Brain Connect; 2021 Oct; 11(8):678-690. PubMed ID: 33813839
    [No Abstract]   [Full Text] [Related]  

  • 27. Network Damage Predicts Clinical Worsening in Multiple Sclerosis: A 6.4-Year Study.
    Rocca MA; Valsasina P; Meani A; Pagani E; Cordani C; Cervellin C; Filippi M
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34021055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A functional magnetic resonance imaging study of patients with secondary progressive multiple sclerosis.
    Rocca MA; Gavazzi C; Mezzapesa DM; Falini A; Colombo B; Mascalchi M; Scotti G; Comi G; Filippi M
    Neuroimage; 2003 Aug; 19(4):1770-7. PubMed ID: 12948731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction.
    Anderson VM; Fisniku LK; Altmann DR; Thompson AJ; Miller DH
    Mult Scler; 2009 Jul; 15(7):811-7. PubMed ID: 19465449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
    Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI-detectable cortical lesions in the cerebellum and their clinical relevance in multiple sclerosis.
    Favaretto A; Lazzarotto A; Poggiali D; Rolma G; Causin F; Rinaldi F; Perini P; Gallo P
    Mult Scler; 2016 Apr; 22(4):494-501. PubMed ID: 26163070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posterior fossa lesion volume and slowed information processing in multiple sclerosis.
    Archibald CJ; Wei X; Scott JN; Wallace CJ; Zhang Y; Metz LM; Mitchell JR
    Brain; 2004 Jul; 127(Pt 7):1526-34. PubMed ID: 15090476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of endogenous antiradical protective system in multiple sclerosis.
    Davitashvili D; Beridze M; Shakarishvili R; Kiziria M; Sanikidze T
    Georgian Med News; 2012 Apr; (205):11-9. PubMed ID: 22665726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in brain functional connectivity patterns are driven by an individual lesion in MS: a resting-state fMRI study.
    Droby A; Yuen KS; Muthuraman M; Reitz SC; Fleischer V; Klein J; Gracien RM; Ziemann U; Deichmann R; Zipp F; Groppa S
    Brain Imaging Behav; 2016 Dec; 10(4):1117-1126. PubMed ID: 26553579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered functional connectivity and performance variability in relapsing-remitting multiple sclerosis.
    Wojtowicz M; Mazerolle EL; Bhan V; Fisk JD
    Mult Scler; 2014 Oct; 20(11):1453-63. PubMed ID: 24619937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous diffuse brain atrophy independent of relapse as a hallmark of multiple sclerosis beginning from relapsing-remitting stage.
    Akaishi T; Fujimori J; Yokote H; Nakashima I
    Clin Neurol Neurosurg; 2024 Jul; 242():108342. PubMed ID: 38772279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Social Cognition Abilities in Patients With Different Multiple Sclerosis Subtypes.
    Henry A; Tourbah A; Chaunu MP; Bakchine S; Montreuil M
    J Int Neuropsychol Soc; 2017 Sep; 23(8):653-664. PubMed ID: 28656885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis.
    Passamonti L; Cerasa A; Liguori M; Gioia MC; Valentino P; Nisticò R; Quattrone A; Fera F
    Brain; 2009 Dec; 132(Pt 12):3380-91. PubMed ID: 19420090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.
    Loitfelder M; Fazekas F; Koschutnig K; Fuchs S; Petrovic K; Ropele S; Pichler A; Jehna M; Langkammer C; Schmidt R; Neuper C; Enzinger C
    PLoS One; 2014; 9(4):e93715. PubMed ID: 24718105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.